Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse
One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.
Financials
| Curr Year EPS Estimate | -0.23 |
| Next Quarter EPS Estimate | -0.05 |
| Profit Margin | -51.07% |
| Operating Margin | -53.44 |
| Return on Assets | -0.08 |
| Return on Equity | -0.24 |
| Revenue | 27.9M |
| Earnings Per Share | -0.16 |
| Revenue Per Share | 0.31 |
| Gross Profit | 19,934,000 |
| Quarterly Revenue Growth | -0.96 |
General
| Name | Compugen Ltd |
| Ticker | CGEN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 74 |
About Compugen Ltd
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been evaluated for the treatment of solid tumors as a monotherapy and in combination of PVRIG/PD-1 and PVRIG/TIGIT, as well as PVRIG/PD-1/TIGIT blockade; Bapotulimab, a therapeutic antibody targeting ILDR2 that is evaluated in Phase I clinical trials in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase III clinical study in patients with advanced or metastatic non-small cell lung cancer. Its preclinical therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and Gilead Sciences, Inc. for the research, development, manufacturing, and commercialization of COM503 and other products. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
Earnings
Warren Buffett's Top Stock Picks Now Come With a 15% Income Bonus Through This Fund
A new ETF is offering investors the chance to follow in the footsteps of one of the world's most successful investors and earn income at the same time.
Revolutionary $20,000 Electric Truck Hits the Market, Stripping Down to the Basics
Michigan-based Slate Auto is preparing to shake up the EV market with the introduction of its minimalist, highly affordable electric truck, the Slate Truck, which is priced under just $20,000.
No.1 Opportunity for 2025 [Take Action Now!] - Ad
Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.
Forget Dogecoin And Shiba Inu — Crypto Analyst Sees This Coin Surging 100%
A crypto analyst has forecasted a 100% increase for Pepe (CRYPTO: PEPE), a mid-cap competitor to Dogecoin (CRYPTO: DOGE) and Shiba Inu (CRYPTO:
UN researchers warn that Asian scam operations are spreading across the rest of the world
BANGKOK (AP) — Transnational organized crime groups in East and Southeast Asia are spreading their lucrative scam operations across the globe in response to increased crackdowns by authorities, according to a U.N. report issued on Monday.
Nvidia Just Committed $500B to AI Infrastructure - Here's the Quiet Ripple Effect - Ad
The AI race isn't just about apps anymore - it's about infrastructure. NVIDIA's $500 billion announcement is a wake-up call: the real opportunity may lie in powering the future, not just coding it. One public company is already stepping in and has support from NVIDIA's inner circle.
SoFi Stock Is Up 11% This Week: What's Going On?
Shares of SoFi Technologies have surged 11% since Monday's open. The company on Tuesday announced a strategic expansion into alternative investments.
Trump Blames GDP Contraction On Biden 'Overhang': 'Nothing To Do With The Tariffs'
President Donald Trump deflects blame for the U.S. economy's 0.3% contraction in the first quarter onto his predecessor, despite clear evidence indicating otherwise.
The Most Important "AI Stock" You've Never Heard Of - Ad
The AI revolution is moving faster than anyone expected. But what no one is talking about is the one company AI simply can't exist without. It may be the single most important AI investment, yet most people don't even know its name. For now. The moment Wall Street catches on, this $20 stock could explode.
How Ryan Coogler Turned $200K In Film School Debt Into A Game-Changing Sinners Deal That Has Hollywood On Edge
Black Panther director Ryan Coogler's latest film Sinners is making waves at the box office and challenging Hollywood's traditional rules.
Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio?
Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, Impinj, Lufax, Tempus AI, Kymera Therapeutics.
Elon Musk Drops Stunning Bombshell? - Ad
Behind closed doors, Musk revealed a game-changing breakthrough technology that could shake the tech world & crush major companies. Why is no one talking about it? Luckily, we had a man on the inside - watch now to see the details & how to profit!
Buffett Remembers Media Legend And Hero Katharine Graham Ahead Of Streaming Documentary: 'She Was One Of A Kind'
A streaming documentary about Katharine Graham shows her unique life and how she became the first female CEO of a Fortune 500 company.
UnitedHealth, T-Mobile And Fiserv Are Among Top 12 Large-Cap Losers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio?
The worst performing large-cap stocks last week were Fiserv, Northrop Grumman, Erie Indemnity, T-Mobile, Watsco, Gold Fields, Aon, AngloGold Ashanti, Ryan Specialty, Tyler Technologies, Kimberly-Clark, and UnitedHealth Group.
Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad
Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.
Elon Musk, Warren Buffett, Jeff Bezos, And 16 US Households Gained $1 Trillion In 2024—An Amount Larger Than Switzerland's Entire Economy
An unprecedented wealth surge has accumulated historic levels of fortune in the hands of a minuscule minority. According to an analysis by economist Gabriel Zucman of UC Berkeley and the Paris School of Economics, only 19 U.S. households added $1 trillion to their net worth in 2024.
Asia Mixed, Europe Markets Gain; Gold Softens On Easing Tensions - Global Markets Today While US Slept
US markets closed higher as strong earnings, trade developments, and recession concerns were weighed. DJIA up 0.75%, S&P 500 up 0.58%, Nasdaq up 0.55%.
AI Is Exploding - But the World's Running Out of the Power to Fuel It - Ad
Every AI app and chatbot model runs on massive computing power - and we're already hitting a wall. One public company is stepping in early to keep AI's engine running. The best part? Most people haven't heard of it yet.
Cathie Wood Bets Against Mark Zuckerberg's Meta Ahead Of Crucial Earnings Report, Loads Up On This Amazon Rival
Cathie Wood's Ark Invest shuffled its portfolio on Tuesday, April 29, 2025, selling Meta shares ahead of earnings while buying into AMD, Shopify, and several biotech names.
Iowa governor sues the Des Moines Register to stop request of emails she claims are protected
DES MOINES, Iowa (AP) — Iowa's governor on Friday sued the Des Moines Register over the newspaper's open records request, asking the court to validate her office's withholding of certain emails she claims are protected.
What's Better Than Drinking Award-Winning Beer? - Ad
Owning stock in the brewery that makes it. That's Westbound & Down's story. They blend gold-medal beer with elite dining, creating a brand customers seek. No wonder they're Colorado's most-awarded brewery and are retail partners with Whole Foods. And 1,835% distribution growth's just the start.
Harassed by Assassin’s Creed gamers, a professor fought back with kindness
HANOVER, N.H. (AP) — Sachi Schmidt-Hori has never played Assassin’s Creed Shadows, but facing an onslaught of online harassment from its fans, she quickly developed her own gameplay style: confronting hate with kindness.
US robot makers hope to beat China in humanoid race. Tariffs could affect their ambitions
BOSTON (AP) — weren't on the agenda of this week's Robotics Summit, where thousands of tech industry workers mingled with humanoid and other robot varieties and talked about how to build and sell a new generation of increasingly autonomous machines.
What Nvidia's $500B Move Could Mean for the Next Tier of Builders - Ad
With big tech locking in supply, smaller players are left waiting. But one public company is building an edge: partnering inside NVIDIA's ecosystem and delivering real compute to real customers.
Scaramucci Calls Sam Bankman-Fried Revelation Worst Day of His Career: 'I Trusted the Guy, I Liked Him'
Anthony Scaramucci, who is known for his short stint as the White House communications director under Donald Trump, has opened up about his professional setbacks, including a significant loss due to a fraudulent act by Sam Bankman-Fried.
Edmunds stylish SUV test: Buick Envista vs. Nissan Kicks
Just because an SUV is small and inexpensive doesn’t mean it has to be as bland as plain oatmeal for breakfast. The and are two great examples. They look good, have surprisingly big interiors, and boast prices in the $20,000s regardless of trim level. That’s largely where the similarities stop, though.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon's greatest invention ever... Yes, even bigger than Tesla or SpaceX.
Warren Buffett's Favorite 'Single Best Measure' For Equities Flashes Buying Signal As US Stocks Rebound
Warren Buffett's favored "Buffett Indicator" suggests U.S. equities may be undervalued, signaling a potential buy opportunity as stocks rebound.
Consumer Tech News (Apr 21-Apr 25): Microsoft's Copilot Gets a Sleek New Look, Apple Under Fire For 'Influence-Peddling' In US-China Trade & More
Sen. Elizabeth Warren requests answers from Apple Inc. CEO Tim Cook over alleged influence-peddling between Apple and Trump administration in trade negotiations with China. Tech companies release mixed earnings results.
This Coin Could Surge Like Bitcoin Did Back in 2013... - Ad
A new coin is emerging in the crypto world. And investing in it now could end up like Bitcoin or Ethereum during their first bull runs.
Japan's finance minister calls U.S. Treasuries "a card" in negotiations with Trump
TOKYO (AP) — Japan’s massive holdings of U.S. Treasurys can be “a card on the table” in negotiations over tariffs with the Trump administration, Finance Minister Katsunobu Kato said Friday.
Amid Cinco de Mayo celebrations, a tax on Mexican tomatoes looms
Guacamole has been spared from tariffs for now. But salsa may not be so lucky.
Nvidia Is About to Shock the World: July 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: July 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Takeaways from AP's report on how Trump's immigration crackdown resonates in the Texas Panhandle
PANHANDLE, Texas (AP) — After his inauguration, President Donald Trump issued a series of ending for immigrants to live and work in the U.S.
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health
Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its .
Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse - Ad
One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.
Trump Meme Coin Down 22% In 7 Days: What Is Going On?
The TRUMP (CRYPTO: TRUMP) meme coin is down 22% over the past seven days, 16 days ahead of a gala dinner for some token holders.
Jeff Sperbeck, former agent for John Elway, dies after injury at 62
LA QUINTA, Calif. (AP) — Jeff Sperbeck, a business partner and former agent for NFL Hall of Famer John Elway, died Wednesday after suffering an injury last weekend at a Southern California golf resort community. He was 62.
The Cross-Chain Giant Set for 1,000%+ Gains - Ad
This multi-chain protocol's volume is exploding while its price is still under the radar. Institutions are moving in fast-get our urgent report before retail wakes up.
Peter Schiff Questions Trump's Bitcoin Ambition Amid Trade Deficit Concerns: 'Resources Are Just Wasted'
Economist Peter Schiff says that President Donald Trump’s Bitcoin (CRYPTO: BTC)-centric policy contradicts his aim of correcting the U.S. trade imbalance with the world.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.